ACO ASSO

• Resection of hepatic and pulmonary metastasis from metastatic esophageal and gastric cancer: a nationwide study.
• Pathogenesis, diagnosis and treatment of premalignant and malignant stages of cholangiocarcinoma in primary sclerosing cholangitis.
• Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
• Stenting for Benign and Malignant Biliary Strictures.
• Laparoscopic right posterior sectionectomy: single-center experience and technical aspects.
• Tumor Size Drives the Prognosis After Hepatic Resection of Solitary Hepatocellular Carcinoma Without Vascular Invasion.
• Combined Transarterial Embolization/Chemoembolization-Based Locoregional Treatment with Sorafenib Prolongs the Survival in Patients with Advanced Hepatocellular Carcinoma and Preserved Liver Function: A Propensity Score Matching Study.
• Microwave ablation compared with hepatic resection for the treatment of hepatocellular carcinoma and liver metastases: a systematic review and meta-analysis.

• Does lymphovascular invasion really associate with decreased overall survival for patients with resected cholangiocarcinoma?
• Long-term perioperative outcomes of pure laparoscopic liver resection versus open liver resection for hepatocellular carcinoma: a retrospective study.
• Preoperative course of patients undergoing endoscopic naso-biliary drainage during the management of resectable perihilar cholangiocarcinoma.
• Prognostic significance of primary tumor sidedness in patients undergoing liver resection for metastatic colorectal cancer.
• Preoperative Chemotherapy and Resection Margin Status in Colorectal Liver Metastasis Patients: A Propensity Score-Matched Analysis.
• Impact of contrast ultrasound diagnosis for patients with liver cancer.
• Extended Lymphadenectomy Versus Regional Lymphadenectomy in Resectable Hilar Cholangiocarcinoma.
• Long-Term Survival Outcomes After Liver Resection for Binodular Hepatocellular Carcinoma: A Multicenter Cohort Study.
• Extended resection of intrahepatic cholangiocarcinoma: A retrospective single-center cohort study.
• Role of Repeat Resection in Patients With Metastatic Colorectal Cancer: A Multicenter Retrospective Study.
• Middle Hepatic Vein Roadmap for a Safe Laparoscopic Right Hepatectomy.
• Robotic Repeat Right Hepatectomy for Recurrent Colorectal Liver Metastasis.
• Long-Term Implications of Unplanned Conversion During Laparoscopic Liver Resection for Hepatocellular Carcinoma.
• A Systematic Review and Meta-Analysis Comparing the Short- and Long-Term Outcomes for Laparoscopic and Open Liver Resections for Hepatocellular Carcinoma: Updated Results from the European Guidelines Meeting on Laparoscopic Liver Surgery, Southampton, UK, 2017.
• Totally Laparoscopic ALPPS: Bilobar Procedure with Preservation of the S3 Portobiliary Triad.
• Clinical Benefit of Preoperative Exercise and Nutritional Therapy for Patients Undergoing Hepato-Pancreato-Biliary Surgeries for Malignancy.
• Intrahepatic Recurrence Patterns Predict Survival After Resection of Colorectal Liver Metastases.
• Ventral Approach to the Middle Hepatic Vein During Laparoscopic Hemihepatectomy.
• Elective Regional Therapy Treatment for Hepatic Adenoma.

• Evaluation of the utility of prognostic models for patients with resected hilar cholangiocarcinoma.
• ASO Author Reflections: Understanding Recurrence Patterns and Time Courses of Intrahepatic Cholangiocarcinoma After Surgery Helps in Postoperative Surveillance and Treatment.
• Hepatocellular carcinoma: killing one bird with two stones.
• Validation of combination treatment with surgical spacer placement and subsequent particle radiotherapy for unresectable hepatocellular carcinoma.
• Single Hepatocellular Carcinoma approached by curative-intent treatment: A propensity score analysis comparing radiofrequency ablation and liver resection.
• The role of sarcopenia in patients with intrahepatic cholangiocarcinoma: Prognostic marker or hyped parameter?
• Macrophages in Colorectal Cancer Liver Metastases.
• Surgery for Recurrent Hepatocellular Carcinoma: Achieving Long-term Survival.
• Conventional Chemoembolization Plus Radiofrequency Ablation versus Surgical Resection for Single, Medium-Sized Hepatocellular Carcinoma: Propensity-Score Matching Analysis.
• Surgical resection of neuroendocrine tumor liver metastases as part of multimodal treatment strategies: A propensity score matching analysis.

• Antimicrobial prophylaxis for 1 day versus 3 days in liver cancer surgery: a randomized controlled non-inferiority trial.
• Risk factors and prognosis of patients with recurrent hepatocellular carcinoma who undergo liver re-resections.
• Synchronous liver metastases and peritoneal carcinomatosis from colorectal cancer: different strategies for curative treatment?
• Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma.
• Hepatocellular carcinoma in the noncirrhotic liver: a literature review.
• Intrahepatic Oxaliplatin and Systemic 5-FU +/- Cetuximab in Chemo-Naïve Patients with Liver Metastases from Colorectal Cancer.
• Hepatectomy for hepatocellular carcinoma after perioperative management of portal hypertension.
• A systematic review and meta-analysis comparing the short- and long-term outcomes for laparoscopic and open liver resections for liver metastases from colorectal cancer.
• Efficacy and safety of radiofrequency ablation versus minimally invasive liver surgery for small hepatocellular carcinoma: a systematic review and meta-analysis.
• Improved outcomes with surgery compared to radiofrequency ablation in the treatment of resectable hepatocellular carcinoma.
• Significant predictors of overall survival in patients with hepatocellular carcinoma after surgical resection.
• Does the site of primary colorectal cancer influence the outcome after resection of isolated liver metastases?
• Treatment options for PNET liver metastases: a systematic review.

• Defining enhanced recovery after resection of peri-hilar cholangiocarcinoma.
• Hepatocellular Carcinoma.
• Minimally invasive resection of posterosuperior liver tumors in the supine position using intra-abdominal trocars.
• Relevance of Preoperative Hyperbilirubinemia in Patients Undergoing Hepatobiliary Resection for Hilar Cholangiocarcinoma.

• Age independent survival benefit for patients with hepatocellular carcinoma (HCC) without metastases at diagnosis: a population-based study.
• Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis.
• Morbidity and mortality after major liver resection in patients with perihilar cholangiocarcinoma: A systematic review and meta-analysis.
• Systematic review and meta-analysis of laparoscopic versus open repeat hepatectomy for recurrent liver cancer.
• Impact of Anatomical Versus Non-anatomical Liver Resection on Short- and Long-Term Outcomes for Patients with Intrahepatic Cholangiocarcinoma.
• Tumor-Infiltrating Lymphocytes and Macrophages in Intrahepatic Cholangiocellular Carcinoma. Impact on Prognosis after Complete Surgery.
• Nonresectional regional therapies for metastatic colorectal cancer to the liver.
• Hepatocellular carcinoma: resection with adjuvant hepatic artery infusion therapy vs resection alone. A systematic review and meta-analysis.
• Robotic hepatectomy for benign and malignant liver tumors.
• Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma.
• Liver Resection for Solitary Transplantable Hepatocellular Carcinoma: The Role of AFP-Score.

• Postoperative Adjuvant Transarterial Chemoembolization Improves Outcomes of Hepatocellular Carcinoma Associated with Hepatic Vein Invasion: A Propensity Score Matching Analysis.
• Malnutrition associated with an increased risk of postoperative complications following hepatectomy in patients with hepatocellular carcinoma.
• Influence of tumor-free resection margins on overall and disease-free survival after resection of colorectal liver metastases.
• Partial liver resection vs. transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria and portal hypertension.

Chirurg 2019

• Liver resection for hepatocellular carcinoma with portal vein infiltration.
• Importance of the lymph node status in patients with hilar cholangiocarcinoma.
• Perihilar cholangiocarcinoma Bismuth type IV: Resection frequently possible.
• Importance of repeated liver resection in recurrent intrahepatic cholangiocarcinoma.
• Treatment effect of liver resection vs. RFA or TACE in hepatocellular carcinoma.
• Importance of portal vein embolization depending on the underlying hepatic malignancy.
• Unresectable intrahepatic cholangiocarcinoma: 50 % resectability after neoadjuvant therapy.

• Surgical therapy of primary hepatic angiosarcoma.
• Preoperative Fluorouracil, Doxorubicin, and Streptozocin for the Treatment of Pancreatic Neuroendocrine Liver Metastases.

• Biomarkers associated with response to regorafenib in patients with hepatocellular carcinoma.
• Initial experience with irreversible electroporation of liver tumours.
• The impact of resection margin and microvascular invasion on long-term prognosis after curative resection of hepatocellular carcinoma: a multi-institutional study.
• Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
• Epidemiology and Management of Hepatocellular Carcinoma.
• Primary Tumor Versus Liver-First Approach for Synchronous Colorectal Liver Metastases: An Association Française de Chirurgie (AFC) Multicenter-Based Study with Propensity Score Analysis.
• Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer.
• Short- and Long-term Outcomes after Robotic and Laparoscopic Liver Resection for Malignancies: A Propensity Score-Matched Study.
• Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review.
• Adjuvant chemotherapy improves oncological outcomes of resectable intrahepatic cholangiocarcinoma: A meta-analysis.
• Multidisciplinary approach of liver metastases from colorectal cancer.
• Is R1 vascular hepatectomy for hepatocellular carcinoma oncologically adequate? Analysis of 327 consecutive patients.
• Liver Resection for Multiple Hepatocellular Carcinomas: A Japanese Nationwide Survey.
• Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?
• Minimal-invasive versus open hepatectomy for hepatocellular carcinoma: Comparison of postoperative outcomes and long-term survivals using propensity score matching analysis.
• Minor laparoscopic liver resection for Hepatocellular Carcinoma is safer than minor open resection, especially for less compensated cirrhotic patients: Propensity score analysis.
• The role of hepatectomy for synchronous liver metastases from pancreatic adenocarcinoma.
• Development of novel biological resection criteria for safe and oncologically satisfying resection of hepatocellular carcinoma.
• Laparoscopic synchronous resection of colorectal cancer and liver metastases: A systematic review.
• Surgical resection of neuroendocrine tumor liver metastases as part of multimodal treatment strategies: A propensity score matching analysis.
• Laparoscopic resection of caudate lobe. Technical strategies for a difficult liver segment – Video article.
• Surgery for perihilar cholangiocarcinoma.
• Biomarkers in colorectal liver metastases.
• Is there a role for Ytrrium-90 in the treatment of unresectable and metastatic intrahepatic cholangiocarcinoma?
• Survival following liver transplantation for liver-only colorectal metastases compared with hepatocellular carcinoma.
• Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent.
• Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma.
• Surgical resection for Bismuth type IV perihilar cholangiocarcinoma.

• Second-line Treatments of Advanced Hepatocellular Carcinoma: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
• Hepatocellular carcinoma: resection with adjuvant hepatic artery infusion therapy vs resection alone. A systematic review and meta-analysis.
• Perioperative Bevacizumab-based Triplet Chemotherapy in Patients With Potentially Resectable Colorectal Cancer Liver Metastases.
• The efficacy and safety of totally laparoscopic hepatectomy for non-cirrhotic hepatocellular carcinoma in the elderly.
• The liver-first approach for locally advanced rectal cancer and synchronous liver metastases.
• A wide-margin liver resection improves long-term outcomes for patients with HBV-related hepatocellular carcinoma with microvascular invasion.
• Outcome after hepatic resection for isolated non-colorectal, non-neuroendocrine liver metastases in 100 patients – the role of the embryologic origin of the primary tumor.
• Safety and efficacy of synchronous robotic surgery for colorectal cancer with liver metastases.

• https://meetinglibrary.asco.org/record/160063/abstract
• https://meetinglibrary.asco.org/record/159164/abstract
• Preoperative drainage for perihilar cholangiocarcinoma – Authors‘ reply.
• Effect of Hyperbilirubinemia on Hepatic Hypertrophy after Portal Vein Embolization and Liver Failure after Heatectomy in Primary Biliary Malignancy.
• Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: a phase III STAH trial.
• Our Rationale of Initiating Neoadjuvant Chemotherapy for Hilar Cholangiocarcinoma: A Proposal of Criteria for „Borderline Resectable“ in the Field of Surgery for Hilar Cholangiocarcinoma.
• Surgical Resection for Recurrent Intrahepatic Cholangiocarcinoma.
• Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib.
• The Short- and Long-Term Outcomes in Elderly Patients with Hepatocellular Carcinoma after Curative Surgery: A Case-Controlled Study with Propensity Score Matching.

• The International Liver Congress, 10.-14.04.2019, Vienna, Austria
• AASLD – The Liver Meeting, 08.-12.11.2019, Boston, USA

• Stereotactic radiofrequency ablation of hepatocellular carcinoma – A histopathological study in explanted livers.
• CT imaging comparison between intraductal papillary neoplasms of the bile duct and papillary cholangiocarcinomas.
• Incidence and Survival Outcomes of Breast Cancer with Synchronous Hepatic Metastases: A Population-Based Study.
• Current survival and treatment trends for surgically resected intrahepatic cholangiocarcinoma in the United States.
• The impact of resection margin on overall survival for patients with colon cancer liver metastasis varied according to the primary cancer location.
• Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence.

• Reply to Risk factors for hepatocellular carcinoma.
• Laparoscopic versus open mesohepatectomy for patients with centrally located hepatocellular carcinoma: a propensity score matched analysis.
• Liver resection for recurrent hepatocellular carcinoma after radiofrequency ablation therapy.
• Laparoscopic synchronous resection of colorectal cancer and liver metastases: A systematic review.

• Hepatocellular carcinoma screening: seeking a reasonable pathway to move forwards… In reply to „Hepatocellular carcinoma screening: seeking robust evidence“ LTE 18-01689.
• Re: Hepatectomy versus stereotactic body radiotherapy for primary early hepatocellular carcinoma.
• Biliary duct stenosis after image-guided high-dose-rate interstitial brachytherapy of central and hilar liver tumors : A systematic analysis of 102 cases.
• The effect of adjuvant chemotherapy in resectable cholangiocarcinoma: A meta-analysis and systematic review.
• Pleural dissemination of cholangiocarcinoma caused by percutaneous transhepatic biliary drainage during the management of resectable cholangiocarcinoma.
• Is disease progression a contraindication for the strategy of portal vein embolization followed by hepatectomy for hepatocellular carcinoma?
• Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma.
• Is Liver Ultrasound Useful as Part of the Surveillance Strategy following Potentially Curative Colorectal Cancer Resection?
• Percutaneous Irreversible Electroporation (IRE) of Hepatic Malignancy: A Bi-institutional Analysis of Safety and Outcomes.
• Potential of ramucirumab in treating hepatocellular carcinoma patients with elevated baseline alpha-fetoprotein.
• The Role of Surgical Resection for Stage IV Gastric Cancer With Synchronous Hepatic Metastasis.
• Neuroendocrine Liver Metastasis-a Specific Set of Markers to Detect Primary Tumor Sites.
• Long-Term Implications of Unplanned Conversion During Laparoscopic Liver Resection for Hepatocellular Carcinoma.
• Minimal-invasive versus open hepatectomy for hepatocellular carcinoma: Comparison of postoperative outcomes and long-term survivals using propensity score matching analysis.
• Minor laparoscopic liver resection for Hepatocellular Carcinoma is safer than minor open resection, especially for less compensated cirrhotic patients: Propensity score analysis.
• The role of hepatectomy for synchronous liver metastases from pancreatic adenocarcinoma.
• Development of novel biological resection criteria for safe and oncologically satisfying resection of hepatocellular carcinoma.
• High-dose rate intraluminal brachytherapy: An effective palliation for cholangiocarcinoma causing bile duct obstruction.
• Preoperative Chemotherapy May Not Influence the Remnant Liver Regenerations and Outcomes After Hepatectomy for Colorectal Liver Metastasis.

• Cholangiocarcinoma: Classification, Histopathology and Molecular Carcinogenesis.
• Radiofrequency ablation versus resection for resectable liver metastases of gastrointestinal stromal tumours: Results from three national centres in China.
• Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence.
• Long-term outcomes of combined hepatocellular-cholangiocarcinoma after hepatectomy or liver transplantation: A systematic review and meta-analysis.
• The power of tumor sizes in predicting the survival of solitary hepatocellular carcinoma patients.
• von Willebrand Factor Antigen Predicts Outcomes in Patients after Liver Resection of Hepatocellular Carcinoma.
• Peritoneal metastasis after emergency hepatectomy and delayed hepatectomy for spontaneous rupture of hepatocellular carcinoma.
• Combined Hepatic Resection and Radio-frequency Ablation for Patients with Colorectal Cancer Liver Metastasis: A Viable Option for Patients with a Large Number of Tumors.
• Time to think: Selecting patients who may benefit from synchronous resection of primary pancreatic cancer and liver metastases.
• Open Liver Resection, Laparoscopic Liver Resection, and Percutaneous Thermal Ablation for Patients with Solitary Small Hepatocellular Carcinoma (≤30 mm): Review of the Literature and Proposal for a Therapeutic Strategy.
• Predictors of Survival after Yttrium-90 Radioembolization for Colorectal Cancer Liver Metastases.
• Major Hepatectomy for Colorectal Liver Metastases in Patients Aged Over 80: A Propensity Score Matching Analysis.
• Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy in the Treatment of Colorectal Liver Metastases: Current Scenario.

Arbeitsgruppensitzung „Leber/Galle/Pankreas“
im Rahmen der 34. Jahrestagung der ACO-ASSO

Zeit: Freitag, 6. Oktober 2017, 18:00 Uhr
Ort:  Wolfgangsaal, Congress Wolfgangsee

Arbeitsgruppensitzung „Leber/Galle/Pankreas“
im Rahmen des Österreichischen Chirurgenkongresses in Wien

Zeit: Mittwoch, 28. Juni 2017, 14:30 bis 16:00 Uhr
Ort:  Business Suite 1, Messe Wien, Congress Center, Messeplatz 1, 1020  Wien 

Arbeitsgruppensitzung „Leber/Galle/Pankreas“
im Rahmen des Österreichischen Chirurgenkongresses in Salzburg

Zeit: Donnerstag, 26. Mai 2016, 10:30 bis 11:00 Uhr
Ort: Saal vereingriff, Salzburg Congress,  Auerspergstraße 6, 5020 Salzburg  

Masstricht, Niederlande
02. – 03. Juni 2016
www.mintonline.org

ESSO Courses and Masterclasses

Wien, KH Rudolfstiftung
7. – 8. September 2015
www.essoweb.org

Chair:
Thomas Gruenberger, Rudolfstiftung Hospital Vienna, AT

Download Program